Page last updated: 2024-09-04

cositecan and Carcinoma, Small Cell

cositecan has been researched along with Carcinoma, Small Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boven, E; Hausheer, FH; Pinedo, HM; Schlüper, HM; Van Hattum, AH	1

Other Studies

1 other study(ies) available for cositecan and Carcinoma, Small Cell

Article	Year
New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer. International journal of cancer, 2000, Oct-15, Volume: 88, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Irinotecan; Lung Neoplasms; Melanoma; Mice; Mice, Nude; Neoplasms; Ovarian Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2000

Article

Year

New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer.

International journal of cancer, 2000, Oct-15, Volume: 88, Issue:2

Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Irinotecan; Lung Neoplasms; Melanoma; Mice; Mice, Nude; Neoplasms; Ovarian Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2000